◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

NuLegacy Gold Corporation

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00
Operating Revenue 0.00 0.00 0.00 0.00 0.00
Cost Of Revenue 255.00 256.00 1,884 2,226 2,226
Gross Profit -255.00 -256.00 -1,884 -2,226 -2,226
Selling General And Administration 20,521 8,922 26,913 131,907 91,523
General And Administrative Expense 20,521 8,922 26,913 131,907 91,523
Other Operating Expenses 71,654 37,655 10,367 50,056 69,215
Operating Expense 92,175 46,577 37,280 181,963 160,738
Operating Income -92,430 -46,833 -39,164 -184,189 -162,964
EBIT -92,430 -46,833 -39,164 -184,189 -162,964
Interest Income 221.00 0.00 0.00 0.00 1,426
Interest Income Non Operating 221.00 0.00 0.00 0.00 1,426
Net Interest Income 221.00 0.00 0.00 0.00 1,426
Other Income Expense -- -1.00 80,401 -34,124 -46.8M
Other Non Operating Income Expenses -- -- -- -- 104.00
Special Income Charges 0.00 0.00 38,298 -33,756 -46.7M
Gain On Sale Of Security -- -1.00 42,103 -368.00 -33,372
Pretax Income -92,209 -46,834 41,237 -218,313 -46.9M
Tax Effect Of Unusual Items 0.00 0.00 12,060 0.00 0.00
Net Income From Continuing And Discontinued Operation -92,209 -46,834 41,237 -218,313 -46.9M
Net Income From Continuing Operation Net Minority Interest -92,209 -46,834 41,237 -218,313 -46.9M
Net Income Including Noncontrolling Interests -92,209 -46,834 41,237 -218,313 -46.9M
Net Income Common Stockholders -92,209 -46,834 41,237 -218,313 -46.9M
Net Income -92,209 -46,834 41,237 -218,313 -46.9M
EBITDA -92,174 -46,578 -37,280 -181,964 -160,738
Normalized EBITDA -92,174 -46,577 -117,681 -147,840 46.6M
Reconciled Depreciation 256.00 255.00 1,884 2,225 2,226
Basic EPS 0.00 0.00 -- 0.00 -17.70
Diluted EPS 0.00 0.00 -- 0.00 -17.70
Basic Average Shares 2.9M 29.0M -- 27.8M 26.6M
Diluted Average Shares 2.9M 29.0M -- 27.8M 26.6M
Total Unusual Items 0.00 -1.00 80,401 -34,124 -46.8M
Total Unusual Items Excluding Goodwill 0.00 -1.00 80,401 -34,124 -46.8M
Tax Rate For Calcs 0.00 0.00 0.15 0.00 0.00
Normalized Income -92,209 -46,833 -27,104 -184,189 -161,434
Diluted NI Availto Com Stockholders -92,209 -46,834 41,237 -218,313 -46.9M
Gain On Sale Of Ppe 0.00 0.00 0.00 0.00 2,706
Impairment Of Capital Assets 0.00 -- -38,298 33,756 46.7M
Insurance And Claims 0.00 100.00 -5,327 22,108 --
Net Income Continuous Operations -92,209 -46,834 41,237 -218,313 -46.9M
Net Non Operating Interest Income Expense 221.00 0.00 0.00 0.00 1,426
Other Gand A 20,216 8,432 26,341 109,214 85,898
Other Special Charges -- -- -- -- -2,017
Reconciled Cost Of Revenue 255.00 256.00 1,884 2,226 2,226
Rent And Landing Fees 305.00 390.00 5,899 585.00 --
Rent Expense Supplemental 305.00 390.00 5,899 585.00 --
Salaries And Wages 0.00 0.00 0.00 0.00 5,625
Total Expenses 92,430 46,833 39,164 184,189 162,964
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Cash And Cash Equivalents 37,618 72,722 105,969 16,448 115,642
Cash Cash Equivalents And Short Term Investments 42,039 77,143 110,390 20,740 119,946
Cash Financial 37,618 72,722 105,969 16,448 115,642
Other Short Term Investments 4,421 4,421 4,421 4,292 4,304
Accounts Receivable 6,069 9,931 7,624 6,110 4,456
Receivables 6,069 9,931 7,624 6,110 4,456
Prepaid Assets 30,429 30,429 18,429 12,407 60,313
Current Assets 78,537 117,503 136,443 39,257 184,715
Gross PPE 361,003 361,002 361,002 363,708 363,708
Accumulated Depreciation -360,491 -360,235 -359,980 -360,802 -358,577
Net PPE 512.00 767.00 1,022 2,906 5,131
Other Non Current Assets 638,563 638,563 646,846 859,352 859,352
Total Non Current Assets 639,075 639,330 647,868 867,573 869,798
Total Assets 717,612 756,833 784,311 906,830 1.1M
Accounts Payable 47,920 45,332 452,985 350,885 370,428
Payables 525,329 472,341 452,985 616,741 543,381
Payables And Accrued Expenses 525,329 472,341 452,985 616,741 543,381
Current Liabilities 525,329 472,341 452,985 616,741 543,381
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 0.00 0.00
Total Liabilities Net Minority Interest 525,329 472,341 452,985 616,741 543,381
Common Stock 59.7M 59.7M 59.7M 59.7M 59.7M
Capital Stock 59.7M 59.7M 59.7M 59.7M 59.7M
Retained Earnings -81.1M -81.0M -80.9M -81.0M -80.8M
Gains Losses Not Affecting Retained Earnings -3.3M -3.3M -3.3M -3.3M -3.3M
Common Stock Equity 192,283 284,492 331,326 290,089 511,132
Stockholders Equity 192,283 284,492 331,326 290,089 511,132
Total Equity Gross Minority Interest 192,283 284,492 331,326 290,089 511,132
Total Capitalization 192,283 284,492 331,326 290,089 511,132
Net Tangible Assets 192,283 284,492 331,326 290,089 511,132
Tangible Book Value 192,283 284,492 331,326 290,089 511,132
Working Capital -446,792 -354,838 -316,542 -577,484 -358,666
Invested Capital 192,283 284,492 331,326 290,089 511,132
Share Issued 2.9M 29.0M 29.0M 29.0M 29.0M
Ordinary Shares Number 2.9M 29.0M 29.0M 29.0M 29.0M
Dueto Related Parties Current 477,409 427,009 0.00 265,856 172,953
Fixed Assets Revaluation Reserve -3.3M -3.3M -3.3M -3.3M -3.3M
Leases 29,509 29,509 29,509 29,509 29,509
Machinery Furniture Equipment 331,493 331,493 331,493 334,199 334,199
Non Current Prepaid Assets -- -- 0.00 5,315 5,315
Other Equity Interest 24.8M 24.8M 24.8M 24.8M 24.8M
Other Properties -- -- -- -- --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Operating Cash Flow -35,104 -41,530 -25,555 -123,035 -114,206
Cash Flow From Continuing Operating Activities -35,104 -41,530 -25,555 -123,035 -114,206
Depreciation And Amortization 256.00 255.00 1,884 2,225 2,226
Depreciation Amortization Depletion 256.00 255.00 1,884 2,225 2,226
Stock Based Compensation -- 0.00 0.00 0.00 0.00
Change In Working Capital 56,849 5,049 -17,539 119,613 74,457
Change In Receivables 3,862 -2,307 -1,514 -1,654 -47.00
Change In Payables And Accrued Expense 52,987 19,356 -10,003 73,361 94,596
Change In Payable 52,987 19,356 -10,003 73,361 94,596
Purchase Of PPE -- -- 0.00 0.00 0.00
Net PPE Purchase And Sale 0.00 0.00 0.00 0.00 0.00
Investing Cash Flow 0.00 8,283 118,727 24,552 -395,932
Cash Flow From Continuing Investing Activities 0.00 8,283 118,727 24,552 -395,932
Issuance Of Capital Stock -- -- -8,063 -2,731 --
Net Common Stock Issuance -- -- -8,063 -2,731 --
Financing Cash Flow -- -- -8,063 -2,731 --
Cash Flow From Continuing Financing Activities -- -- -8,063 -2,731 --
Effect Of Exchange Rate Changes 0.00 0.00 4,412 2,020 36,166
Changes In Cash -35,104 -33,247 85,109 -101,214 -67,078
Beginning Cash Position 72,722 105,969 16,448 115,642 146,554
End Cash Position 37,618 72,722 105,969 16,448 115,642
Free Cash Flow -35,104 -41,530 -25,555 227,832 -465,073
Asset Impairment Charge -- -- -38,298 33,756 --
Change In Prepaid Assets 0.00 -12,000 -6,022 47,906 -20,092
Common Stock Issuance -- -- -8,063 -2,731 --
Depreciation 256.00 255.00 1,884 2,225 2,226
Gain Loss On Investment Securities -- -- -- -- --
Net Income From Continuing Operations -92,209 -46,834 41,237 -218,312 -46.9M
Net Other Investing Changes 0.00 8,283 118,727 -326,315 -45,065
Operating Gains Losses -- -- -12,839 -47,106 -28,333
Sale Of PPE 0.00 0.00 0.00 0.00 0.00
NEWS
Loading news...
TRENDING
Loading...